To manage COVID-19, various drug targets, like spike and envelope proteins, membrane proteins, nucleocapsid proteins, endosomal pH, angiotensin-converting-enzyme (ACE) inhibitors, and proteases, have been explored. This evidence concerns the gene ACE and COVID-19.